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Abstract
As a feed additive, ascorbic acid has been shown to have a protective effect against bacterial and viral diseases
and to reduce the impact of detrimental stress in chickens. This study examined the effect of ascorbic acid
treatment on in vitro heterophil function by examining random migration and phagocytosisa nd bacterialk
illing of Staphylococcuasu reus. Heterophils were evaluated in broiler chickens ranging from 5 to 16 wk of age,
and age differences were seen. Significant increases in bacterial killing were found in heterophils treated with
ascorbic acid, and this difference tended to be greater in chickens from 5 to 10.5 wk of age. No significant
differences were found in phagocytosis or random migration, but ascorbic acid tended to decrease random
migration. The most significant effect on in vitro heterophil function was an increase in bacterial killing.
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AVIAN DISEASES 43:656-663, 1999 
The Effects of Ascorbic Acid on In Vitro 
Heterophil Function 
Claire B. AndreasenA and Dagmar E. FrankB 
ADepartment of Veterinary Pathology 
BVeterinary Microbiology and Preventive Medicine 
College of Veterinary Medicine, Iowa State University, Ames, IA 50014 
Received 11 December 1998 
SUMMARY. As a feed additive, ascorbic acid has been shown to have a protective effect 
against bacterial and viral diseases and to reduce the impact of detrimental stress in chickens. 
This study examined the effect of ascorbic acid treatment on in vitro heterophil function by 
examining random migration and phagocytosis and bacterial killing of Staphylococcus aureus. 
Heterophils were evaluated in broiler chickens ranging from 5 to 16 wk of age, and age 
differences were seen. Significant increases in bacterial killing were found in heterophils 
treated with ascorbic acid, and this difference tended to be greater in chickens from 5 to 
10.5 wk of age. No significant differences were found in phagocytosis or random migration, 
but ascorbic acid tended to decrease random migration. The most significant effect on in 
vitro heterophil function was an increase in bacterial killing. 
RESUMEN. Efectos del icido asc6rbico sobre la funci6n de los heter6filos in vitro. 
El icido asc6rbico como aditivo del alimento ha demostrado tener un efecto protector 
contra enfermedades bacterianas y virales, lo mismo que para reducir el deterioro que causa 
el estres en las aves. En este estudio se examin6 el efecto del tratamiento con icido asc6rbico 
sobre la funci6n (in vitro) de los heter6filos observando la migraci6n al azar, la fagocitosis y 
la muerte bacteriana del Staphylococcus aureus. Los heter6filos fueron evaluados en aves de 5 
a 16 semanas de edad. Se observaron diferencias por edad. Se encontraron diferencias sig- 
nificantes en la muerte bacteriana en los heter6filos tratados con icido asc6rbico y estas 
diferencias tuvieron la tendencia de ser mayores en las aves de 5 a 10.5 semanas de edad. 
No se observaron diferencias significantes en la fagocitosis o en la migraci6n al azar pero se 
pudo observar la tendencia del icido asc6rbico de reducir la migraci6n al azar. El efecto in 
vitro mis significante sobre la funci6n de los heter6filos fue el aumento de la muerte bac- 
teriana. 
Key words: ascorbic acid, bacterial killing, heterophil function, random migration, phago- 
cytosis, Staphylococcus aureus 
Abbreviations: CPM = counts per minute; EDTA = ethylenediaminetetraacetic acid; FBS 
= fetal bovine serum; HBSS = Hanks' buffered salt solution; MTT = 3-(4,5-dimethylthia- 
zol-2-y)-2,5-diphenyl-tetrazolium bromide; OD = optical density; PBSS = phosphate-buff- 
ered salt solution; TSB = tryptic soy broth 
Staphylococcal tenosynovitis and osteomye- 
litis are worldwide problems of broiler and 
broiler-breeder chickens and turkeys that result 
in increased condemnations at slaughter and 
decreased weight gain and egg production due 
to bacteremia and decreased mobility (20). This 
disease has resulted in economic losses in the 
poultry industry, and previous surveys have 
identified that staphylococcal tenosynovitis/ar- 
thritis and osteomyelitis account for a major 
proportion of musculoskeletal disease in poul- 
try (28). The disease pathogenesis is poorly de- 
fined, but decreased leukocyte function, espe- 
cially heterophils, may contribute to the chron- 
ic debilitating nature of the disease (5). This 
syndrome responds poorly to antibiotics and, 
so far, immunization has not been effective. 
Critically important to both the human and 
veterinary medical communities is that staphy- 
lococcal bacteria are becoming resistant to an- 
tibiotics, e.g., the emergence of methicillin- and 
vancomycin-resistant strains of staphylococci. 
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An avian model has been used to examine avian 
heterophil function in staphylococcal tenosyn- 
ovitis/arthritis/osteomyelitis (4,8). Acquired de- 
fects in avian heterophil function have been 
documented in association with both chronic 
staphylococcal infections and staphylococcal 
septicemia (5). Defects in neutrophil function 
have been documented in human beings with 
chronic bacterial infections including Staphylo- 
coccus aureus (2,18). 
The use of ascorbic acid to improve cell 
function and protect against disease has been 
advocated in staphylococcal infections of hu- 
mans (18,30) and various diseases of poultry 
(13,19). In humans, as chronic staphylococcal 
infections progress, plasma ascorbic acid con- 
centrations decrease (18). We previously dem- 
onstrated that ascorbic acid concentrations de- 
creased during experimental staphylococcal in- 
fections in poultry. In humans, ascorbic acid 
has been documented to upregulate neutrophil 
chemotaxis, phagocytosis, and bacterial killing 
as well as to result in clinical improvement in 
staphylococcal infections (18). As a means of 
therapy, ascorbic acid offers the important ad- 
vantages of being nontoxic and economical and 
not conferring antibiotic resistance. 
There is a need to determine if heterophil 
function, including phagocytosis and bacterial 
killing, can be increased by ascorbic acid treat- 
ment because this might contribute to the de- 
creased mortality reported in the poultry liter- 
ature. This study investigates the in vitro effects 
of ascorbic acid on heterophil random migra- 
tion and phagocytosis and bacterial killing of S. 
aureus. 
MATERIALS AND METHODS 
Preliminary data. An in vivo pilot study was 
conducted to determine plasma ascorbic acid concen- 
trations in 6-to-8-wk-old broiler chickens with ex- 
perimental staphylococcal arthritis (1 x 106 S. aureus 
921-1 intravenous inoculation) (4) without ascorbic 
acid feed supplementation (n = 4) and with ascorbic 
acid feed supplementation (n = 3). Controls con- 
sisted of healthy chickens fed diets without (n = 3) 
and with ascorbic acid supplementation (n = 4). The 
in vivo study compared chickens being fed a regular 
ration (Start and Growth; Purina Mills, Inc., St. Lou- 
is, MO) and a 1000 ppm ascorbic acid-supplemented 
(Hoffman-Roche, Inc., Nutley, NJ) ration with and 
without experimental staphylococcal infections. Plas- 
ma for ascorbic acid analysis was collected into ethy- 
lenediaminetetraacetic acid (EDTA) vacutainer tubes, 
placed on ice, and immediately centrifuged at 4 C; 
the plasma was collected and stored at -70 C until 
analyzed. Plasma ascorbic acid analysis was performed 
by reverse phase high-performance liquid chromatog- 
raphy with electrochemical detection at Michigan 
State University, College of Veterinary Medicine, Nu- 
tritional Laboratory, East Lansing, MI, and results 
were reported in micromoles per liter. 
Experimental design. Heterophils were collect- 
ed from clinically healthy nonvaccinated Arbor Acres 
x Ross broiler chickens with complete blood counts 
within normal reference intervals. Chickens were 
housed in the Iowa State University Laboratory An- 
imal Resource Facility with 16 hr light and 8 hr dark 
cycles and provided growth ration and water ad li- 
bitum. Heterophils were harvested from chickens at 
-10.5 wk and >11.0 wk of age, and assays were 
repeated over a 12 wk time period. Paired samples 
were used in each assay, and repetitions for each assay 
type are indicated below. Heterophils were incubated 
with either ascorbic acid (1 x 10-1 M) or Hanks' 
buffered salt solution (HBSS) without calcium or 
magnesium with 0.1% fetal bovine serum (FBS). As- 
says for random migration, phagocytosis, and bacte- 
rial killing were conducted at 41 C. 
Heterophil separation and incubation. Het- 
erophils were collected from 5-to-16-wk-old chickens 
and separated by a slight modification of a previously 
described technique (3,7). Solutions and reagents 
used in the heterophil separation were prewarmed in 
an incubator at 41 C for 20 min. A volume of 6 ml 
of whole blood was collected into 12-ml syringes with 
a 1:9 ratio of 10% EDTA (ED 2SS; Sigma Chemical 
Co., St. Louis, MO) to blood. The blood was gently 
mixed with 4 ml of 1% methylcellulose (25 cps, M- 
6385; Sigma) in 15-ml polypropylene tubes, and 
then the sample was divided into two tubes with 5 
ml each and centrifuged at 25 g. After centrifugation, 
the plasma, with the buffy coat layer above the eryth- 
rocytes, was removed into separate tubes, and the 
erythrocyte interface was gently washed with HBSS 
without calcium or magnesium (14175-020, Gibco- 
BRL, Grand Island, NY), with 0.1% fetal bovine se- 
rum (FBS) (Intergen Co., Purchase, NY), to harvest 
the remaining heterophils. The tubes were filled with 
HBSS with 0.1% FBS, mixed, and centrifuged at 375 
x g for 10 min. After centrifugation, the supernatant 
was discarded and the cell pellets were resuspended 
in HBSS with 0.1% FBS to 3 ml and placed on 
Ficoll-Hypaque gradients (Sigma) (specific gravity 
1.077, 3 ml; over specific gravity 1.119, 3 ml). After 
centrifugation for 25 min at 260 X g, the 1.077/ 
1.119 interface and 1.119 band were retained, and 
the top layer, including the white band of mononu- 
clear cells, was discarded. The tubes were filled with 
HBSS with 0.1% FBS, inverted, and centrifuged at 
375 x g for 10 min. The cell pellets were resuspen- 
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ded to 3 ml in 1 50-ml polypropylene tube, then 25 
ml of 0.87% NH4Cl in 0.1% KHCO3 was added, 
and the tubes were rocked for 7 min to lyse the re- 
maining erythrocytes. After the 7 min, HBSS with 
0.1% FBS was added for a total volume of 50 ml, 
mixed, and centrifuged for 15 min at 400 x g. The 
supernatant was discarded, and the cell pellet was re- 
suspended to 2 ml and then divided into two 15-ml 
polypropylene tubes, filled with HBSS with 0.1% 
FBS, and centrifuged for 10 min at 375 x g. In the 
control tube, the heterophils were initially suspended 
to 1 ml in HBSS with 0.1% FBS and counted with 
an eosinophil unopette (Becton-Dickinson, Ruther- 
ford, NJ) and hemacytometer. Differential leukocyte 
counts were performed on cytospin preparations to 
exclude eosinophils from the final heterophil count, 
and then cells were suspended to an initial concen- 
tration of 3 x 106 heterophils/ml. The heterophils in 
the ascorbic acid sample were suspended at the same 
cell concentration with 1 x 10-1 M sodium ascorbate 
(A4034 L-ascorbic acid sodium; Sigma) in HBSS on 
the basis of previously published ascorbic acid con- 
centrations (2) and incubated for 30 min at 21 C 
(2,31). After incubation, the cells were rinsed with 
HBSS with 0.1% FBS, centrifuged at 375 x g, and 
used for assays. The final heterophil concentration 
was adjusted for each assay. Heterophil purity 
(>95%) was examined by cytospin preparations and 
viability determined by trypan blue dye exclusion 
(>95%). In preliminary assays, the concentration of 
ascorbic acid was doubled, but no significant effect 
was noted (data not shown). 
Bacteria and pooled sera. A characterized S. au- 
reus strain 921-1, isolated from affected joints in a 
case of tenosynovitis, was used for heterophil/bacte- 
rial assays (6). Bacteria were kept frozen at -70 C 
and grown on blood agar plates; single colonies were 
harvested and grown in tryptic soy broth (TSB) over- 
night for 14 hr prior to each assay. For the bacterial 
killing assay, bacteria were washed three times for 15 
min at 1290 x g at 4 C, opsonized for 20 min, and 
suspended to 5 x 107 colony-forming units/ml in 
HBSS, standardized by spectrophotometry, and ver- 
ified by colony counts. The 125I labeling of S. aureus 
for phagocytic assays was performed as previously de- 
scribed (24) with slight modifications. Two milliliters 
of an overnight culture was inoculated into 500 ml 
of brain-heart infusion broth containing 500 RCi 1251 
(Amersham, Arlington Heights, IL) and 10-5 M fluo- 
rodeoxyuridine (125FUdR) (F0305; Sigma) and incu- 
bated for 24 hr at 37 C. After incubation, the bac- 
teria were divided into 10 50-ml vials and centrifuged 
at 1000 x g for 20 min; the supernatant was removed 
and heat-killed for 1 hr at 56 C. Bacteria were then 
washed with phosphate-buffered salt solution (PBSS) 
10 min at 450 x g, the supernatant was removed, 
bacterial counts were standardized by spectrophotom- 
etry, and 125S-iododeoxyuridine-labeled bacteria were 
stored at -70 C until used. 
Opsonization was done with pooled nonimmune 
avian sera collected from broiler chickens raised in 
Oregon and Iowa, filtered, and stored at -70 C. Se- 
rum titers against S. aureus were determined by mi- 
crotiter plate agglutination, as previously described 
(3), to be 1:32. 
Random migration. Random migration under 
agarose (n = 13 paired samples) was used to measure 
the ability of heterophils to move randomly (1,24). 
Agar plates were prepared with buffered sodium bi- 
carbonate (NaHCO3, 0.026 M, pH 7.2) added to 10 
x M199 medium with Hanks' salts and L-glutamine 
(11181-039; Gibco-BRL) containing 10% pooled 
normal chicken serum, 0.8% agarose (Indubiose A37 
HAA; IBF Biotechnics Inc., Columbia, MD), and 
1% penicillin-streptomycin solution (P0781; Sigma) 
(1). Five-milliliter amounts of the agarose medium 
were dispensed into 60 x 15-mm tissue culture petri 
plates (Becton-Dickinson Labware, Lincoln Park, 
NJ), allowed to solidify, and stored in an airtight con- 
tainer at 4 C with humidity. Heterophils were diluted 
to 5 x 107 heterophils/ml and 10 pA was placed in 
prepunched 2.0-mm agar wells with samples run in 
duplicate. Plates were placed in a humidified incu- 
bator with 5% CO2 at 41 C and incubated for 18 
hr. After incubation, the plates were fixed with 8% 
glutaraldehyde for 60 min, the agar was removed, and 
adherent heterophils were stained with 0.1% crystal 
violet for 10 min, dried, and examined. The area of 
migration was determined by measuring the radius 
with a microscope ocular grid. The circular migration 
pattern (in millimeters2) was calculated by the for- 
mula A = rrR2 and subtracting the area of the well 
from the total area. 
Phagocytosis. The percentage of phagocytosis of 
S. aureus (n = 16 paired samples) was determined by 
measuring the ability of heterophils to ingest opson- 
ized 1251-iododeoxyuridine-labeled S. aureus (24). In 
preliminary studies, pooled normal chicken serum 
was compared with a previously characterized staph- 
ylococcal antisera (3) as an opsonin, and no signifi- 
cant differences were found in the phagocytic assay 
(data not shown). The S. aureus (100 W1), 50 p• of 1:10 dilution of pooled normal chicken serum, and 
Earle's basic salt solution (24010-068; Gibco-BRL) 
were incubated for 15 min in a 41 C shaking water 
bath. Fifty microliters of a 2.5 x 106 heterophil/ml 
suspension was added and shaken for 10 min. Then 
0.5 ml of PBSS with 0.1 unit/ml of lysostaphin 
(L2898; Sigma) was added to the tubes and incubat- 
ed for 30 min, after which 3.0 ml of cold PBSS was 
added to stop the reaction. Tubes were then centri- 
fuged at 1250 x g at 4 C for 10 min and washed 
twice with PBSS. The supernatant was aspirated and 
discarded, and the final cell pellet, containing ingest- 
ed labeled bacteria, was measured in a gamma coun- 
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ter to determine the counts per minute (CPM) of 
radioactivity. Standards included a standard tube with 
S. aureus, no heterophils, and no lysostaphin and a 
background tube with all reactants except hetero- 
phils. All assays were performed as duplicates. 
Bacterial killing. Heterophils were collected 
from 21 paired samples. Assays were conducted at 41 
C by the 3-(4,5-dimethylthiazol-2-y)-2,5-diphenyl- 
tetrazolium bromide (MTT) bactericidal assay in 96- 
well microtiter plates (62409-068, Nunc plates; 
VWR Scientific Products, Batavia, IL) by slight mod- 
ification of a published technique (7). All test and 
control wells were performed in quadruplicate. In this 
assay, the remaining live bacteria, after further cell 
incubation, reduce MTT and produce purple form- 
azan. Bacteria were opsonized with 20% pooled 
chicken serum for 20 min. Standard curves were cre- 
ated with 100%, 50%, 25%, 12.5%, 6.25%, and 
3.1% bacterial concentrations verified by plate colony 
counts. In separate wells, bacteria were incubated 
with 1 x 10-1 M sodium ascorbate (A4034 L-ascor- 
bic acid sodium; Sigma) in HBSS to rule out direct 
killing of bacteria by ascorbic acid. Then 1 x 106 
opsonized bacteria in 50 p1 of HBSS were added to 
test and bacterial control wells. Test wells contained 
3 x 105 heterophils in 100 pl HBSS with 0.2% FBS, 
and cell control wells contained the previously de- 
scribed contents without the bacteria. The plates were 
centrifuged (400 x g for 5 min) to increase bacteria 
and heterophil contact. Initially, incubation times of 
0 (no further incubation after the 5-min contact 
time), 30, and 60 min were performed, and the 0- 
and 30-min incubations of heterophils and bacteria 
were optimal. These two incubation times were run 
for each assay. After incubation, plates were centri- 
fuged at 600 x g for 10 min to pellet, and 120 ?l1 
of HBSS was removed from control and test wells. 
Sterile water (80 pl) was added to control and test 
wells to lyse the heterophils and incubated 5 min, 
and then 150 pl of TSB was added. A second in- 
cubation, found to be optimal at 2 hr in 5% CO2 
for bacterial amplification, was followed by the ad- 
dition of 10 p1 of MTT (M2128; Sigma) to each 
well, and incubated for 10 min to allow the color 
change due to formazan. Ten microliters of 0.04 N 
HCI in isopropanol was added to each well to dis- 
solve the MTT (1:25 dilution) for 10 min. The plates 
were covered and stored overnight, and the optical 
density (OD) was read at 560 nm on an automated 
shaking microplate reader after sitting at 25 C for 30 
min. Bacterial killing assay (MTT) results are re- 
ported as OD readings (7) with the lower OD read- 
ing indicating the fewer surviving bacteria. 
Statistical analysis. The percentage of phagocy- 
tosis was converted to arc sines prior to statistical 
analysis (29). Values of OD readings and migration 
(in mm2) were used for the MTT and random mi- 
gration analyses, respectively. For the heterophil func- 
tion assays and plasma ascorbic acid concentrations, 
an analysis of variance was performed, and when sig- 
nificant differences among means were identified, Fis- 
her's least significant difference was calculated for all 
paired means. Significant differences were examined 
in all age groups (5, 6, 6.5, 8, 10.5, 11, 13, 14, 15, 
and 16 wk of age), and statistical comparisons were 
made in chickens 
-10.5 wk and >11.0 wk of age. 
The alpha level was determined at 0.05 or 0.06, as 
indicated in results. For phagocytic assays, the mean 
percentages of phagocytosis +SD were calculated to 
determine the percentages of phagocytosis with and 
without ascorbic acid treatment of heterophils. 
Percentage of ingestion was determined as follows: 
% ingestion 
= {[(CPM in reaction tube) 
- (CPM in background tube)] 
+ [(CPM in standard tube) 
- (CPM in background tube)]} x 100. 
For the MTT assay, the percentage change in OD 
readings from incubation with ascorbic acid was cal- 
culated as 
% change in OD 
= {[(OD without ascorbic acid treatment) 
- (OD with ascorbic acid treatment)] 
+ OD without ascorbic acid treatment} x 100. 
Also for the MTT assay, the percentage of bacterial 
killing was calculated as 
% bacterial killing 
= {[(OD bacterial control) 
- (OD test - OD cell control)] 
- 
OD bacterial control} x 100. 
RESULTS 
Preliminary data. The plasma ascorbic 
acid concentrations were increased in both 
healthy chickens and staphylococcal-infected 
chickens when supplemented with ascorbic 
acid, as opposed to the same groups without 
supplementation. The means +SD for plasma 
ascorbic acid concentrations were as follows: 
healthy control chickens with ascorbic acid sup- 
plementation = 133.99 ? 23.17 jM/liter; 
healthy control chickens with no ascorbic acid 
supplementation = 68.51 + 13.16 jM/liter; 
staphylococcal-infected chickens with ascorbic 
acid supplementation = 81.95 + 18.17 jM/ 
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Fig. 1. Mean (diagonal bars) and standard devia- 
tion (solid bars) for plasma ascorbic acid concentra- 
tions in four sample groups. Group 1, healthy chick- 
ens supplemented with 1000 ppm ascorbic acid in 
feed; group 2, healthy chickens with no ascorbic acid 
supplementation; group 3, chickens with experimen- 
tal staphylococcal infection that were supplemented 
with 1000 ppm ascorbic acid in feed; and group 4, 
chickens with experimental staphylococcal infection 
and no ascorbic acid supplementation. All groups 
were significantly different (P 
-< 
0.05) except group 
2 compared with group 3. 
liter; and staphylococcal infection with no as- 
corbic acid supplementation = 23.28 ? 4.70 
jIM/liter (Fig. 1). Means were significantly dif- 
ferent (P 
- 
0.05) when all groups were com- 
pared with the exception of the comparison of 
healthy control chickens compared with staph- 
ylococcal-infected chickens with ascorbic acid 
supplementation. 
Heterophil separation. Initially, not 
enough heterophils were collected on the same 
day to run all assays from individual chickens, 
but a majority of chickens had all three assays 
performed. The collection of peripheral blood 
was increased to 12 to 24 ml to run multiple 
assays with no adverse effect on adult broilers. 
The heterophil separation procedure was fol- 
lowed with the addition of more tubes for the 
methylcellulose and gradient steps because it 
was important to maintain the stated blood to 
reagent ratios. The yield of heterophils from 6 
ml of blood ranged from 4 x 106/pl to 8.5 x 
106/il, and from 12 ml of blood, the range was 
8 x 106/pl to 18 X 106/pl. The critical factors 
for maximum heterophil yield were accurate 
centrifugation speeds and avoidance of any mi- 
croclots in the blood samples. 
Random migration. Over all age groups, 
no significant differences (P - 0.05) were 
found in random migration between hetero- 
phils treated with ascorbic acid or HBSS, but 
comparisons of individual chickens (n = 4) did 
have significant differences (P 
- 
0.05). When 
age groups were examined, no significant dif- 
ferences (P 
- 
0.05) were noted. In all age 
groups, ascorbic acid tended to decrease ran- 
dom migration of heterophils (mean ? SD, 
22.9 ? 12.7 mm2) compared with heterophils 
treated with HBSS (26.1 ? 15.6 mm2). Ten of 
13 chickens assayed had decreased random mi- 
gration when the heterophils were incubated 
with ascorbic acid. 
Phagocytosis. For phagocytosis, no signif- 
icant differences 
(P- 
0.05) were found be- 
tween heterophils treated with ascorbic acid or 
HBSS for any age group. The means ? SD 
phagocytosis were 21.4 ? 7.7% for heterophils 
treated with HBSS and 20.4 ? 5.7% for het- 
erophils incubated with ascorbic acid across all 
age groups. 
Bacterial killing. In the MTT assay, a sig- 
nificant (P 
- 
0.05) increase in heterophil kill- 
ing of S. aureus was seen when heterophils were 
incubated with ascorbic acid at 1 x 10-1 M 
and compared with bacterial killing when in- 
cubated in HBSS. There was a trend (signifi- 
cant at P 
- 
0.06) for heterophils from chickens 
-10.5 wk of age to have greater increases in 
bacterial killing vs. chickens -11.0 wk of age. 
When heterophils were incubated with ascorbic 
acid, the mean percentage of decrease in OD 
for chickens ?10.5 wk of age was 27.6% vs. 
18.2% for chickens ?11.0 wk of age. When 
ascorbic acid-incubated heterophils were com- 
pared with HBSS incubation, individual bird 
heterophils varied from 16% to 44% in the de- 
crease of OD that corresponded to an increase 
in bacterial killing. For all age groups, bacterial 
killing was 64 ? 12% for heterophils treated 
with HBSS and 71 ? 12% for heterophils 
treated with ascorbic acid. No direct bacterial 
killing was observed when ascorbic acid was in- 
cubated with bacteria, but there was a slight 
trend for bacterial numbers to increase when 
compared with incubation in HBSS. 
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DISCUSSION 
The use of ascorbic acid to improve cell 
function and protect against disease has been 
advocated in both human medicine (18,23) 
and veterinary medicine, including poultry 
medicine (13,19). In poultry, decreased ascor- 
bic acid concentrations have been associated 
with stress (16), and administration of ascorbic 
acid has been associated with a protective effect 
against stress, e.g., corticosterone release 
(13,27). In poultry, ascorbic acid added to feed 
or water has been shown to ameliorate the ef- 
fects of Escherichia coli and infectious bronchitis 
virus (9,13,14). Recently, ascorbic acid was 
found to decrease mortality in broiler ascites 
and had no effect on performance parameters 
(17). 
A trend for ascorbic acid to decrease random 
migration of heterophils was found in our 
study. The effect of ascorbic acid may aid in 
keeping the inflammatory cells at the site of 
infection. In cattle, ascorbic acid decreased ran- 
dom migration (25). Additionally, studies in 
cattle demonstrated that the subcutaneous in- 
jection of ascorbic acid reversed the effects of 
dexamethasone alteration of neutrophil migra- 
tion, oxidative metabolism, and antibody-de- 
pendent cytotoxicity (25). 
We did not see differences in the percentage 
of phagocytosis in heterophils treated with as- 
corbic acid and those treated with HBSS. The 
percentage of phagocytosis was similar, but 
slightly decreased, compared with previous re- 
ports of staphylococcal ingestion by avian het- 
erophils (3,4,7). These differences could be due 
to the assay type because prior assays used flow 
cytometric evaluation of phagocytosis (3,7). In 
cattle, ascorbic acid tended to enhance S. aureus 
ingestion by bovine neutrophils (25). Follow- 
up studies were not performed to examine the 
use of ascorbic acid in disease prevention or as 
an additive to cattle feed. What effect the ru- 
men microflora might have on ascorbic acid 
metabolism is unknown. 
Of the assays used, significant differences 
were seen in cell-associated bacterial killing 
with the MTT assay. Even though the cells are 
washed in the MTT assay, complete removal of 
external bacteria cannot be guaranteed, and 
hence the assay is categorized as cell-associated 
bacterial killing. Because subsequent bacterial 
amplification is performed, the changes in OD 
readings are probably a more accurate reflection 
of heterophil-associated bacterial killing than 
comparisons of percentage of bacterial killing. 
Because ascorbic acid apparently will increase 
in vitro staphylococcal killing, the mechanism 
of ascorbic acid may be directly intracellular, 
extracellular, or both. The importance of ascor- 
bic acid function as an extracellular antioxidant 
protecting the granulocyte, and possibly pro- 
longing its functional life span, may be more 
critical for neutrophils that contain myeloper- 
oxidase than for heterophils that primarily kill 
organisms via oxygen-independent pathways 
(11). 
We found decreased plasma ascorbic acid 
concentrations in chickens with staphylococcal 
arthritis/tenosynovitis (Fig. 1). As chronic in- 
fections progress, plasma ascorbic acid levels de- 
crease, possibly because of increased utilization 
(18,26). Between 150 and 1000 ppm of ascor- 
bic acid in poultry feeds have been shown to 
decrease mortality under different disease and 
stress conditions (13,16,19). Recently, more 
stable formulations for ascorbic acid are avail- 
able, and recommendations for supplementa- 
tion amounts have changed (Dr. Bond, Roche, 
Ames, IA, pers. comm.). Generally, ascorbic 
acid is not regarded as a dietary requirement 
for poultry because poultry can synthesize the 
vitamin to meet body requirements under nor- 
mal conditions (15,27). The natural ascorbic 
acid content of grains and feedstuffs is often 
below 10 ppm, but increased plasma ascorbic 
acid levels are rapidly achieved with feed or wa- 
ter supplementation within 8 hr (22,26). From 
prior studies, it appears that the longer the sup- 
plementation is given, the longer the plasma 
ascorbic acid concentrations may be sustained. 
The importance of ascorbic acid for granu- 
locyte function has been documented in hu- 
mans. Neutrophils from humans have been 
shown to accumulate significant amounts of as- 
corbic acid intracellularly (10,31). When bac- 
terial infections occur, granulocytes go to the 
site of infection, and their functional capability 
appears to be related to ascorbic acid concen- 
tration. Depletion of ascorbic acid results in a 
reduction of phagocytosis and killing (26). 
Theories for ascorbic acid upregulation of neu- 
trophils have included prevention of autooxi- 
dation from neutrophil granules at the site of 
infection and improvement of phagocytosis and 
chemotaxis by modulation of tubulin tyrosi- 
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nolation (18); however, the mechanism remains 
unknown. 
Defects in neutrophil function have been 
documented in humans with chronic bacterial 
infections including S. aureus (2,12,18,21), and 
decreased heterophil chemotaxis was found in 
a field case of chickens with S. aureus (6). In 
human patients with S. aureus infections, sup- 
plementation with ascorbic acid resulted in 
upregulation of neutrophil function, including 
chemotaxis, phagocytosis, and bacterial killing, 
and clinical improvement (2,18,23,30). In pa- 
tients with neutrophil function defects and con- 
current bacterial infections, in vitro incubation 
of neutrophils with 1 x 10-1 M sodium ascor- 
bate restored neutrophil function motility (2). 
In our studies of poultry, heterophil function 
was evaluated in clinically healthy chickens, and 
the effect of ascorbic acid may not be as im- 
portant in upregulation of cell function in 
healthy animals vs. animals with chronic disease 
that may have decreased concentrations of as- 
corbic acid. 
For these reasons, the literature tends to sup- 
port that poultry feed supplementation with as- 
corbic acid is beneficial, especially in the face 
of stress or disease, but the mechanisms, other 
than general assumptions about antioxidant ef- 
fects, remain undefined (19). Because cortisol- 
type hormones are known to suppress mam- 
malian neutrophil (12) and heterophil function 
(13), the beneficial effects of ascorbic acid dur- 
ing stress, such as decreased mortality, may be 
due to upregulation of heterophil function and 
protection against infectious diseases. Our stud- 
ies indicate that in vitro bacterial killing by het- 
erophils is upregulated by ascorbic acid; there- 
fore, prevention or amelioration of poultry 
staphylococcal infections with ascorbic acid 
supplementation may be possible. This would 
indicate a need to evaluate the effects of ascor- 
bic acid on heterophil function during a disease 
such as S. aureus; however, obtaining data from 
these types of experimental studies can be com- 
plicated by the fact that heterophil function can 
be upregulated by the short-term infectious 
process (4). Because of public concern about 
antibiotic use in meat products and because an- 
tibiotic-resistant strains of bacteria are increas- 
ing, ascorbic acid is an intriguing candidate to 
serve as a natural, acceptable feed additive that 
may aid in disease prevention. 
REFERENCES 
1. Agrawal, P. K., and D. L. Reynolds. Evalua- 
tion of the cell-mediated immune response of chick- 
ens vaccinated with Newcastle disease virus as deter- 
mined by the under-agarose leukocyte-migration-in- 
hibition technique. Avian Dis. 35:360-364. 1991. 
2. Anderson, R., and A. Theron. Effects of ascor- 
bate on leucocytes. Part III. In vitro and in vivo stim- 
ulation of abnormal neutrophil motility by ascorbate. 
S. Afr. Med. J. 56:429-433. 1979. 
3. Andreasen, C. B., J. R. Andreasen, A. E. 
Sonn, and J. A. Oughton. Comparison of the effect 
of different opsonins on the phagocytosis of fluores- 
cein-labeled staphylococcal bacteria by chicken het- 
erophils. Avian Dis. 40:778-782. 1996. 
4. Andreasen, C. B., K. S. Latimer, B. G. Har- 
mon, J. R. Glisson, J. M. Golden, and J. Brown. 
Heterophil function in healthy chickens and in chick- 
ens with experimentally induced staphylococcal te- 
nosynovitis. Vet. Pathol. 28:419-427. 1991. 
5. Andreasen, J. R., C. B. Andreasen, M. Anwer, 
and A. E. Sonn. Heterophil chemotaxis in chickens 
with natural staphylococcal infections. Avian Dis. 37: 
284-289. 1993. 
6. Andreasen, J. R., C. B. Andreasen, M. Anwer, 
and A. E. Sonn. Chicken heterophil chemotaxis using 
Staphylococcus-generated chemoattractants. Avian 
Dis. 37:835-838. 1993. 
7. Brooks, R. L., D. I. Bounous, and C. B. An- 
dreasen. Functional comparison of avian heterophils 
with human and canine neutrophils. Comp. Hae- 
matol. Int. 6:153-159. 1996. 
8. Daum, R. S., W. H. Davis, B. Farris, R. J. 
Campeau, D. M. Mulvihill, and S. M. Shane. A 
model of Staphylococcus aureus bacteremia, septic ar- 
thritis, and osteomyelitis in chickens. J. Orthop. Res. 
8:804-813. 1990. 
9. Davelaar, E G., and J. Van Dan Bos. Ascorbic 
acid and infectious bronchitis infections in broilers. 
Avian Pathol. 21:581-589. 1992. 
10. Dwengar, A., M. Funck, B. Lueken, G. 
Schweitzer, and U. Lehmann. Effect of ascorbic acid 
on neutrophil functions and hypoxanthine/xanthine 
oxidase-generated, oxygen-derived radicals. Eur. J. 
Clin. Chem. Biochem. 30:187-191. 1992. 
11. Evans, E. W., G. G. Beach, J. Wunderlich, 
and B. G. Harmon. Isolation of antimicrobial pep- 
tides from avian heterophils. J. Leukoc. Biol. 56:661- 
665. 1994. 
12. Gallin, J. I., D. G. Wright, H. L. Malech, J. 
M. Davis, M. S. Klempner, and C. H. Kirkpatrick. 
Disorders of phagocyte chemotaxis. Ann. Intern. 
Med. 92:520-538. 1980. 
13. Gross, W. B. Effect of ascorbic acid on stress 
and disease in chickens. Avian Dis. 36:688-692. 
1992. 
This content downloaded from 129.186.1.55 on Tue, 11 Mar 2014 15:17:58 PM
All use subject to JSTOR Terms and Conditions
Ascorbic acid effects on heterophil function 663 
14. Gross, W. B., D. Jones, and J. Cherry. Effect 
of ascorbic acid on the disease caused by Escherichia 
coli challenge infection. Avian Dis. 32:407-409. 
1988. 
15. Kratzer, E H., H. J. Almquist, and P. Vohra. 
Effect of diet on growth and plasma ascorbic acid in 
chicks. Poult. Sci. 75:82-89. 1996. 
16. Kutlu, H. R., and J. M. Forbes. Changes in 
growth and blood parameters in heat stressed broiler 
chicks in response to dietary ascorbic acid. Livest. 
Prod. Sci. 36:335-350. 1993. 
17. Ladmakhi, M. H., N. Buys, E. Dewil, G. Ra- 
himi, and E. Decuypere. The prophylactic effect of 
vitamin C supplementation on broiler ascites, inci- 
dence and plasma thyroid concentration. Avian 
Pathol. 26:33-44. 1997. 
18. Levy, R., O. Shriker, A. Porath, K. Riesenberg, 
and E Schlaeffer. Vitamin C for the treatment of 
recurrent furunculosis in patients with impaired neu- 
trophil functions. J. Infect. Dis. 173:1502-1505. 
1996. 
19. McKee, J. S., and P. C. Harrison. Effect of 
supplemental ascorbic acid on the performance of 
broiler chickens exposed to multiple concurrent 
stressors. Poult. Sci. 74:1772-1785. 1995. 
20. Mutalib, A., C. Riddell, and A. D. Osborne. 
Studies on the pathogenesis of staphylococcal osteo- 
myelitis in chickens. I. Effect of stress on experimen- 
tally induced osteomyelitis. Avian Dis. 27:141-156. 
1983. 
21. O'Driscoll, M., L. Crawford, and W. D. Big- 
gar. Clinical features and abnormal neutrophil func- 
tion in disseminated staphylococcal disease. Pediatr. 
Infect. Dis. J. 4:137-141. 1985. 
22. Pardue, S. L., J. P. Thaxton, and J. Brake. 
Plasma ascorbic acid concentration following ascorbic 
acid loading in chicks. Poult. Sci. 63:2492-2496. 
1984. 
23. Patrone, E, E Dallergi, E. Bonvini, E Miner- 
vini, and C. Sacchetti. Disorders of neutrophil func- 
tion in children with recurrent pyogenic infections. 
Med. Microbiol. Immunol. 171:113-122. 1982. 
24. Roth, J. A., and M. L. Kaeberle. Evaluation 
of bovine polymorphonuclear leukocyte function. 
Vet. Immunol. Immunopathol. 2:157-174. 1981. 
25. Roth, J. A., and M. L. Kaeberle. In vivo effect 
of ascorbic acid on neutrophil function in healthy 
and dexamethasone-treated cattle. Am. J. Vet. Res. 
46:2434-2436. 1985. 
26. Rund, B. Vitamin C plays role in immunity. 
Poult. Dig. 48:44-50. 1989. 
27. Satterlee, D. G., I. Aguilera-Quintana, B. J. 
Munn, and B. A. Krautmann. Vitamin C ameliora- 
tion of the adrenal stress response in broiler chickens 
being prepared for slaughter. Comp. Biochem. 
Physiol. 94:569-574. 1989. 
28. Skeeles, J. K. Staphylococcosis. In: Diseases of 
poultry, 9th ed. B. W. Calnek, C. W. Beard, W. M. 
Reid, and H. W. Yoder, Jr., eds. Iowa State University 
Press, Ames, IA. pp. 293-299. 1991. 
29. Snedecor, G. W., and W. G. Cochran. Statis- 
tical methods, 7th ed. Iowa State University Press, 
Ames, IA. 1980. 
30. Vohra, K., A. J. Khan, V. Telang, W Rosen- 
feld, and H. E. Evans. Improvement of neutrophil 
migration by systemic vitamin C in neonates. J. Pe- 
rinatol. Med. 10:134-136. 1990. 
31. Washko, P., D. Rotrosen, and M. Levine. As- 
corbic acid transport and accumulation in human 
neutrophils. J. Biol. Chem. 264:18996-19002. 1989. 
ACKNOWLEDGMENTS 
This study was funded by USDA Formula Funds 
administered by Iowa State University. We thank Alli- 
son Florance for statistical analysis. Preliminary feed- 
ing trial data were funded by the Oregon State Col- 
lege of Veterinary Medicine, and we acknowledge 
Anita Sonn for technical assistance in that project. 
This content downloaded from 129.186.1.55 on Tue, 11 Mar 2014 15:17:58 PM
All use subject to JSTOR Terms and Conditions
